Cargando…
Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test
BACKGROUND: Mild cognitive impairment (MCI) is a heterogeneous clinical entity that comprises the prodromal phase of Alzheimer's disease (Pr-AD). New biomarkers are useful in detecting Pr-AD, but they are not universally available. We aimed to investigate baseline clinical and neuropsychologica...
Autores principales: | Pozueta, Ana, Rodríguez-Rodríguez, Eloy, Vazquez-Higuera, José Luis, Mateo, Ignacio, Sánchez-Juan, Pascual, González-Perez, Soraya, Berciano, José, Combarros, Onofre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135527/ https://www.ncbi.nlm.nih.gov/pubmed/21702929 http://dx.doi.org/10.1186/1471-2377-11-78 |
Ejemplares similares
-
No association of CDK5 genetic variants with Alzheimer's disease risk
por: Vázquez-Higuera, José Luis, et al.
Publicado: (2009) -
Caspase-1 genetic variation is not associated with Alzheimer's disease risk
por: Vázquez-Higuera, José Luis, et al.
Publicado: (2010) -
DYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort
por: Vázquez-Higuera, José Luis, et al.
Publicado: (2009) -
Genetic variation in the tau protein phosphatase-2A pathway is not associated with Alzheimer's disease risk
por: Vázquez-Higuera, José L, et al.
Publicado: (2011) -
Comparison of DBFS with MoCA and MMSE tools for MCI screening
por: Chad Chew, Eun Yip, et al.
Publicado: (2023)